Improved identification of viable myocardium using second harmonic imaging during dobutamine stress echocardiography

Heart. 2001 Dec;86(6):672-8. doi: 10.1136/heart.86.6.672.

Abstract

Objective: To determine whether, compared with fundamental imaging, second harmonic imaging can improve the accuracy of dobutamine stress echocardiography for identifying viable myocardium, using nuclear imaging as a reference.

Patients: 30 patients with chronic left ventricular dysfunction (mean (SD) age, 60 (8) years; 22 men).

Methods: Dobutamine stress echocardiography was carried out in all patients using both fundamental and second harmonic imaging. All patients underwent dual isotope simultaneous acquisition single photon emission computed tomography (DISA-SPECT) with (99m)technetium-tetrofosmin/(18)F-fluorodeoxyglucose on a separate day. Myocardial viability was considered present by dobutamine stress echocardiography when segments with severe dysfunction showed a biphasic sustained improvement or an ischaemic response. Viability criteria on DISA-SPECT were normal or mildly reduced perfusion and metabolism, or perfusion/metabolism mismatch.

Results: Using fundamental imaging, 330 segments showed severe dysfunction at baseline; 144 (44%) were considered viable. The agreement between dobutamine stress echocardiography by fundamental imaging and DISA-SPECT was 78%, kappa = 0.56. Using second harmonic imaging, 288 segments showed severe dysfunction; 138 (48%) were viable. The agreement between dobutamine stress echocardiography and DISA-SPECT was significantly better when second harmonic imaging was used (89%, kappa = 0.77, p = 0.001 v fundamental imaging).

Conclusions: Second harmonic imaging applied during dobutamine stress echocardiography increases the agreement with DISA-SPECT for detecting myocardial viability.

MeSH terms

  • Cardiotonic Agents*
  • Dobutamine*
  • Echocardiography, Stress / methods*
  • Female
  • Fluorodeoxyglucose F18
  • Humans
  • Male
  • Middle Aged
  • Myocardium*
  • Radiopharmaceuticals
  • Sensitivity and Specificity
  • Tomography, Emission-Computed, Single-Photon / methods
  • Ventricular Dysfunction, Left / diagnostic imaging*

Substances

  • Cardiotonic Agents
  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18
  • Dobutamine